On Tuesday, Cellebrite DI Ltd (NASDAQ: CLBT) was -0.34% drop from the session before settling in for the closing price of $17.52. A 52-week range for CLBT has been $6.36 – $17.61.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Technology sector was 18.79%. When this article was written, the company’s average yearly earnings per share was at 51.68%. With a float of $65.42 million, this company’s outstanding shares have now reached $203.23 million.
Considering the fact that the conglomerate employs 1008 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 84.19%, operating margin of 13.85%, and the pretax margin is -26.72%.
Cellebrite DI Ltd (CLBT) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Cellebrite DI Ltd stocks. The insider ownership of Cellebrite DI Ltd is 68.56%, while institutional ownership is 33.48%. The most recent insider transaction that took place on Sep 16 ’24, was worth 1,751,000. Before that another transaction happened on Sep 04 ’24, when Company’s Officer proposed sale 8,919 for $16.95, making the entire transaction worth $151,177.
Cellebrite DI Ltd (CLBT) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted 0.1 earnings per share (EPS) during the time that was better than consensus figure (set at 0.05) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 51.68% per share during the next fiscal year.
Cellebrite DI Ltd (NASDAQ: CLBT) Trading Performance Indicators
You can see what Cellebrite DI Ltd (CLBT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.69. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.02. Likewise, its price to free cash flow for the trailing twelve months is 40.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.53, a number that is poised to hit 0.08 in the next quarter and is forecasted to reach 0.30 in one year’s time.
Technical Analysis of Cellebrite DI Ltd (CLBT)
Compared to the last year’s volume of 1.14 million, its volume of 0.82 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 93.95%. Additionally, its Average True Range was 0.56.
During the past 100 days, Cellebrite DI Ltd’s (CLBT) raw stochastic average was set at 97.76%, which indicates a significant increase from 89.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 23.60% in the past 14 days, which was lower than the 40.19% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.70, while its 200-day Moving Average is $11.50. Nevertheless, the first resistance level for the watch stands at $17.69 in the near term. At $17.93, the stock is likely to face the second major resistance level. The third major resistance level sits at $18.23. If the price goes on to break the first support level at $17.16, it is likely to go to the next support level at $16.86. Now, if the price goes above the second support level, the third support stands at $16.62.
Cellebrite DI Ltd (NASDAQ: CLBT) Key Stats
There are 205,932K outstanding shares of the company, which has a market capitalization of 3.63 billion. As of now, sales total 325,110 K while income totals -81,100 K. Its latest quarter income was 95,710 K while its last quarter net income were -23,810 K.
